Impact factor molecular cancer therapeutics
WitrynaImpact. 5.738 Impact Factor. 4.5 CiteScore. ... Cancer Molecular Targets and Therapeutics Cardio-Oncology Gastrointestinal Cancers: Colorectal Cancer ... Frontiers is well aware of the potential impact of published research both on future research and on society and, hence, does not support superficial review, light review or no-review ... WitrynaMolecular Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1476-4598. ... About Molecular Cancer. Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer ...
Impact factor molecular cancer therapeutics
Did you know?
WitrynaImpact Factor Cancer Discovery: 41.226 Cancer Epidemiology, Biomarkers & Prevention: 5.594 Cancer Immunology Research: 13.345 Cancer Prevention Research: 4.317 … Witryna15 June 2024. About the journal. Aims & Scope. Molecular Therapy Oncolyticsis an international, online-only, open-access journal focusing on the development and …
WitrynaJournal impact factor : 0.53 ; Average acceptance to publication time (5-7 days) Average article processing time (30-45 days) Less than 5 volumes 30 days ... Biochimica et Biophysica Acta - Reviews on Cancer, Breast Cancer Research, Neuro-Oncology, Molecular Cancer Therapeutics, Cancer, Journal of Thoracic Oncology. Witryna1 kwi 2024 · About the Journal. Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, … MCT First Disclosures. First Disclosures in Molecular Cancer Therapeutics present … Channing J. Der Vishva Dixit Ethan Dmitrovsky Suzanne A. Eccles Heinz … Read Volume 21 Issue 9 of Molecular Cancer Therapeutics. Skip to Main … A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive … Molecular Cancer Research ; Molecular Cancer Therapeutics ; For Authors . … Abstract. Loss of the gene SMARCB1 drives the development of malignant … Abstract. T-cell bispecific antibodies (TCB) are engineered molecules that bind both … Abstract. YES1 is a nonreceptor tyrosine kinase that belongs to the SRC family of …
WitrynaScope. Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to …
Witryna8 kwi 2024 · Attenuating aberrant transcriptional circuits holds great promise for the treatment of numerous diseases, including cancer. However, development of transcriptional inhibitors is hampered by the lack of a generally accepted functional cellular readout to characterize their target specificity and on-target activity. We …
Witryna6 paź 2024 · In this Editorial, Christine Watson highlights the content of The FEBS Journal ’s Special Issue on Cancer Therapeutics. Through an exciting collection of recent articles, this issue covers a broad repertoire of cancer therapeutic approaches. Several articles discuss broad-spectrum applications, such as immunotherapy and … smart classroom featuresWitrynaTranslational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the …. View full aims & scope. smart classroom devicesWitrynaSpecific Categories: Small Molecule Therapeutics: Discovery and preclinical development of small molecule entities. Large Molecule Therapeutics: Novel large … smart classroom ppt downloadWitrynaBackground: Radionuclides emitting Auger electrons (AEs) with low (0.02–50 keV) energy, short (0.0007–40 µm) range, and high (1–10 keV/µm) linear energy transfer may have an important role in the targeted radionuclide therapy of metastatic and disseminated disease. Erbium-165 is a pure AE-emitting radionuclide … smart classroom iot softwareWitrynaAs an Institutional postdoctoral researcher in different academic institutes, I hold an excellent command in the field of Molecular biology, Molecular analysis technology, RNA biology, Cell biology, Genetics & Genomics especially in novel platforms for therapeutics, molecular targets driving Cancer Drug Resistance for potential … smart classroom introductionWitrynaDr Lopamudra Das Roy (Distinguished Cancer Scientist-Research Professor), Social Entrepreneur, resigned from her rewarding career in 2024, to create and grow BCH as her Full-time pro bono ... smart classroom conceptWitrynaMedical Researcher Horticultural Hobbyist Junior Scientist Transhumanist Research Focus: • Molecular and Genomic Medicine, CRISPR Cas-9 Associated Genomic Therapy • Viral Therapeutics, Viral vector development, Developments of Novel Platforms for Investigations of Infections with Unknown Aetiology • Emerging … hillcrest lunch menu